Graft loss · kidney transplant recipients
ACE Inhibitors showed no clear difference in graft loss compared with calcium channel blockers (low certainty).
1 finding from 1 review
GFR · kidney transplant recipients
1 finding from 1 review
Acute rejection · kidney transplant recipients
It is very uncertain whether ACE Inhibitors changes acute rejection compared with calcium channel blockers (very low certainty).
1 finding from 1 review
Proteinuria · kidney transplant recipients
1 finding from 1 review
Haemoglobin (g/dL) · kidney transplant recipients
1 finding from 1 review
Blood loss: post‐treatment haematocrit (%) · kidney transplant recipients
1 finding from 1 review
Intervention not reported
Body weight change (kg) · participants living with overweight or obesity
1 finding from 1 review
Intervention not reported
Health‐related quality of life · participants living with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events · participants living with overweight or obesity
1 finding from 1 review
Intervention not reported
All‐cause mortality · participants living with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Morbidity · participants living with overweight or obesity
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Anthropometric measures other than body weight a) BMI b) Waist circumference c) Fat mass · participants living with overweight or obesity
1 finding from 1 review
Cardiac T2* value · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
MIC · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
LVEF (echocardiography) · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Ferritin (µg/L) · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Liver T2* value · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
LIC · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Adverse events · or population: people with transfusion‐dependent beta thalassaemia
1 finding from 1 review
Quality of life · premenopausal women (age 18–32.7 years)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found